The medium and long-term debt of pharmaceutical firm Unimed listed on Tunisia stock exchange grew by 448% year to year in S1, 2019 to reach TND20.8 million.
The firm explains that during the period under review, it borrowed TND4.8 million from banks for its expansion project.
According to Moroccan media citing Charfeddine Ridha (photo), UNIMED’s managing director, an TND80 million-investment plan is announced for the expansion of the firms’ laboratories.
Despite the growth of its debt, Unimed’s turnover rose by 124% year on year to reach TND31.1 million thanks to its sales on local and foreign markets that quarter.
Chamberline MOKO
South Africa led with 35% of total deal value, ahead of Kenya and Egypt Inbound deal value ro...
Safran invests €280m to build one of the world's largest landing gear plants in Morocco, crea...
Industrial, jewelry and silverware demand expected to decline in 2026. Physical investment ...
This week in Africa, Africa CDC is stepping up its drive for health sovereignty, building new partne...
Global South Utilities (GSU) has begun building a 5 MWp hybrid solar plant with 5 MWh battery st...
Socapalm sells Eséka palm oil mill to Opalm Staff transferred with rights preserved, bonus planned Deal aims to cut 300,000-ton national palm oil...
IMF sees Cameroon growth rising on mining, power gains GDP to recover to 3.3% in 2026, exceed 4% Fiscal deficit widened in 2025, debt risk remains...
Togo reviews investment policy to align with AfCFTA protocol Three-day workshop held with IISD and key stakeholders Reforms aim to attract...
Kinshasa metro line could launch on Nov. 27, 2027 Government finalizing studies, financing and PPP agreement Project includes seven rail lines, 173...
The University of Lomé on Wednesday opened a fossil and rock exhibition hall showcasing specimens from the country’s coastal sedimentary basin. Led by the...
Senegal, Morocco resume talks on film co-production pact Countries seek revised agreement on training, distribution Partnership produced two...